DexCom (DXCM) insider buying
13 open-market purchases of DXCM by DexCom's executives and directors since September 2025, worth $1M in total, from SEC Form 4 filings.
The most recent: Ro Khanna bought — on February 17, 2026.
The biggest buyer over the period is Jacob Steven Leach: 1 purchase, $1M.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 9 | $0 |
| 2025 | 4 | $1M |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Jacob Steven Leach | 1 | $1M |
| Ro Khanna | 6 | $0 |
| John Boozman | 3 | $0 |
| Michael T. Mccaul | 3 | $0 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Feb 17, 2026 | Ro Khanna |
0 | $70.43 | — | — |
| Feb 17, 2026 | Ro Khanna |
0 | $70.43 | — | — |
| Feb 17, 2026 | Ro Khanna |
0 | $70.43 | — | — |
| Jan 29, 2026 | Ro Khanna |
0 | $74.00 | — | — |
| Jan 29, 2026 | Ro Khanna |
0 | $74.00 | — | — |
| Jan 29, 2026 | Ro Khanna |
0 | $74.00 | — | — |
| Jan 26, 2026 | John Boozman |
0 | $73.34 | — | — |
| Jan 26, 2026 | John Boozman |
0 | $73.34 | — | — |
| Jan 26, 2026 | John Boozman |
0 | $73.34 | — | — |
| Nov 10, 2025 | Jacob Steven Leach |
18,200 | $55.04 | $1M | Form 4 |
| Sep 22, 2025 | Michael T. Mccaul |
0 | $69.51 | — | — |
| Sep 22, 2025 | Michael T. Mccaul |
0 | $69.51 | — | — |
| Sep 22, 2025 | Michael T. Mccaul |
0 | $69.51 | — | — |
Questions
Are DexCom insiders buying the stock?
13 open-market purchases of DXCM by DexCom's executives and directors since September 2025, worth $1M in total, from SEC Form 4 filings. The most recent: Ro Khanna bought — on February 17, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From DexCom's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.